References
- Food and Drug Administration. Combating antibiotic resistance. Consumer Health Information 2008. Available at: http://www.fda.gov/downloads/ForConsumers/Consumer Updates/UCM143470.pdf
- Pechere JC, Hughes D, Kardas P, Cornaglia G. Non-compliance with antibiotic therapy for acute community infections: a global survey. Int J Antimicrob Agents 2007; 29:245–53.
- Schrag SJ, Pena C, Fernandez J, Sánchez J, Gómez V, Pérez E, . Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage. JAMA 2001; 286:49–56.
- Daum RS. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med 2007; 357:380–90.
- Karageorgopoulos DE, Falagas ME. Current control and treatment of multi-drug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008;8:751–62.
- Gales AC, Jones RN, Turnidge J, Rennie R, Ramphal R. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis 2001;32 (Suppl 2):S146–55.